Peter Huebener
Impact in
- Hepatology top 1%
- Liver physiology and pathology
- Liver Disease and Transplantation
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research
Papers in
-
- Advanced Glycation End Products research 9
-
- Liver Disease and Transplantation 6
- Co-authors
- Robert F. SchwabeJean‐Philippe PradèreXueru MuDianne H. DapitoIngmar MederackeChristine HsuJuliane S. TroegerClaudia Hernandez
- Journals
- Journal of Clinical Investigation (4 papers)Liver International (2 papers)Journal of Crohn s and Colitis (2 papers)Cell Metabolism (1 paper)Journal of Hepatology (1 paper)
- Partner nations
- GermanyUnited StatesJapan
In The Last Decade
Peter Huebener
24 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Hepatology 916
- Clinical Biochemistry 185
- Immunology 538
- Epidemiology 876
- Pharmacology 127
Countries citing papers authored by Peter Huebener
This map shows the geographic impact of Peter Huebener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Huebener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Huebener more than expected).
Fields of papers citing papers by Peter Huebener
This network shows the impact of papers produced by Peter Huebener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Huebener. The network helps show where Peter Huebener may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Huebener, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 6 | |
| 5 | 2022 | 1 | |
| 6 | 2020 | 27 | |
| 7 | 2019 | 12 | |
| 8 | 2019 | 26 | |
| 9 | 2018 | 91 | |
| 10 | 2018 | 1 | |
| 11 | Damage-associated molecular patterns in cancer: a double-edged sword Hit paper breakdown → | 2016 | 357 |
| 12 | 2014 | 12 | |
| 13 | 2014 | 63 | |
| 14 | 2014 | 23 | |
| 15 | Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology Hit paper breakdown → | 2013 | 1035 |
| 16 | 2012 | 115 | |
| 17 | 2008 | 153 | |
| 18 | 2007 | 51 | |
| 19 | 2006 | 59 | |
| 20 | 2006 | 277 |
About Peter Huebener
Peter Huebener is a scholar working on Clinical Biochemistry, Hepatology, Immunology, Epidemiology and Pharmacology, having authored 24 papers that have together received 2.7k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (9 papers), Liver Disease Diagnosis and Treatment (8 papers), Liver Disease and Transplantation (6 papers), Cardiac Fibrosis and Remodeling (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Organ Transplantation Techniques and Outcomes (3 papers), Tissue Engineering and Regenerative Medicine (2 papers) and Bone and Dental Protein Studies (2 papers). The work is most often cited by research in Hepatology (916 citations), Clinical Biochemistry (185 citations), Immunology (538 citations), Epidemiology (876 citations) and Pharmacology (127 citations). Peter Huebener has collaborated with scholars based in Germany, United States and Japan. Frequent co-authors include Robert F. Schwabe, Jean‐Philippe Pradère, Xueru Mu, Dianne H. Dapito, Ingmar Mederacke, Christine Hsu, Juliane S. Troeger, Claudia Hernandez, Nikolaos G. Frangogiannis and Daniel J. Antoine. Their work appears in journals such as Journal of Clinical Investigation, Liver International, Journal of Crohn s and Colitis, Cell Metabolism and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.